COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,618 Articles (22,913 medRxiv, 8,705 bioRxiv)

Most recent first Previous |  Page 3146: Articles 31451-31460  | Next

Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., Zhang, X., Zhang, M., Wu, S., Song, J., Chen, T., Han, M., Li, S., Luo, X., Zhao, J., Ning, Q.
10.1101/2020.02.16.20023903 — Posted: 2020-02-19 Discussion: Onsite
Association between 2019-nCoV transmission and N95 respirator use
Wang, X., Pan, Z., Cheng, Z.
10.1101/2020.02.18.20021881 — Posted: 2020-02-19
Structure and immune recognition of the porcine epidemic diarrhea virus spike protein
Kirchdoerfer, R., Bhandari, M., Martini, O., Sewell, L. M., Bangaru, S., Yoon, K.-J., Ward, A.
10.1101/2020.02.18.955195 — Posted: 2020-02-19
Estimation of the final size of the coronavirus epidemic by the logistic model
batista, m.
10.1101/2020.02.16.20023606 — Posted: 2020-02-18
Evaluating new evidence in the early dynamics of the novel coronavirus COVID-19 outbreak in Wuhan, China with real time domestic traffic and potential asymptomatic transmissions
Zhou, C.
10.1101/2020.02.15.20023440 — Posted: 2020-02-18 Discussion: Onsite
When will the battle against novel coronavirus end in Wuhan: a SEIR modeling analysis
zhang, l., wan, k., chen, j., lu, c., dong, l., wu, z.
10.1101/2020.02.16.20023804 — Posted: 2020-02-18
Risk map of the novel coronavirus (2019-nCoV) in China: proportionate control is needed
Li, X., Zhao, X., Lou, Y., Sun, Y.
10.1101/2020.02.16.20023838 — Posted: 2020-02-18
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., Xiong, L., Guo, C., Tian, J., Luo, J., Yao, J., Pang, R., Shen, H., Peng, C., Liu, T., Zhang, Q., Wu, J., Xu, L., Lu, S., Wang, B., Weng, Z., Han, C., Zhu, H., Zhou, R., Zhou, H., Chen, X., Ye, P., Zhu, B., He, S., He, Y., Jie, S., Wei, P., Zhang, J., Lu, Y., Wang, W., Zhang, L., Li, L., Zhou, F., Wang, J., Dittmer, U., Lu, M., Hu, Y., Yang, D., Zheng, X.
10.1101/2020.02.16.20023671 — Posted: 2020-02-18 Discussion: Onsite | Offsite
Simulating and Forecasting the Cumulative Confirmed Cases of SARS-CoV-2 in China by Boltzmann Function-based Regression Analyses
Fu, X., Ying, Q., Zeng, T., Long, T., Wang, Y.
10.1101/2020.02.16.20023564 — Posted: 2020-02-18 Discussion: Onsite
Estimating the Case Fatality Risk of COVID-19 using Cases from Outside China
Wilson, N., Kvalsvig, A., Telfar Barnard, L., Baker, M.
10.1101/2020.02.15.20023499 — Posted: 2020-02-18 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).